Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine

N Engl J Med. 2022 Jul 28;387(4):374-376. doi: 10.1056/NEJMc2206711. Epub 2022 Jun 29.

Authors

Odile Launay¹, Marine Cachanado², Liem B Luong Nguyen³, Laetitia Ninove⁴, Marie Lachâtre³, Inès Ben Ghezala⁵, Marc Bardou⁵, Catherine Schmidt-Mutter⁶, Karine Lacombe⁷, Fabrice Laine⁸, Jean-Sébastien Allain⁸, Elisabeth Botelho-Nevers⁹, Marie-Pierre Tavolacci¹⁰, Christian Chidiac¹¹, Patricia Pavese¹², Bertrand Dussol¹³, Stéphane Priet⁴, Dominique Deplanque¹⁴, Amel Touati², Laureen Curci³, Eleine Konate³, Nadine Ben Hamouda¹⁵, Anissa Besbes¹⁵, Eunice Nubret¹⁶, Florence Capelle¹⁶, Laurence Berard², Alexandra Rousseau², Eric Tartour¹⁵, Tabassome Simon⁷, Xavier de Lamballerie⁴

Affiliations

¹ Université Paris Cité, Paris, France odile.launay@aphp.fr.
² Hôpital St. Antoine, Paris, France.
³ Hôpital Cochin, Paris, France.
⁴ Aix-Marseille University, Marseille, France.
⁵ University Hospital, Dijon, France.
⁶ Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
⁷ Sorbonne Université, Paris, France.
⁸ Centre Hospitalier Universitaire (CHU) Rennes, Rennes, France.
⁹ CHU de Saint-Etienne, Saint-Etienne, France.
¹⁰ CHU Rouen, Rouen, France.
¹¹ Hospices Civils de Lyon, Lyon, France.
¹² CHU de Grenoble Alpes, Grenoble, France.
¹³ Hôpitaux Universitaires de Marseille, Marseille, France.
¹⁴ CHU Lille, Lille, France.
¹⁵ Hôpital Européen Georges Pompidou, Paris, France.
¹⁶ Assistance Publique-Hôpitaux de Paris, Paris, France.

No abstract available

Publication types

Letter

MeSH terms

Adjuvants, Immunologic* / adverse effects
Antibodies, Viral
Humans
Immunization, Secondary* / adverse effects
Immunogenicity, Vaccine*
Vaccines, Synthetic* / adverse effects
Vaccines, Synthetic* / immunology

Substances

Adjuvants, Immunologic
Antibodies, Viral
Vaccines, Synthetic